Clinical Evaluation of DAILIES TOTAL 1 Multifocal Compared to 1-Day Acuvue Moist Multifocal in a Japanese Population

Clinical Evaluation of DAILIES TOTAL 1 Multifocal Compared to 1-Day Acuvue Moist Multifocal in a Japanese Population - Clinical Evaluation of DAILIES TOTAL 1 Multifocal Compared to 1-Day Acuvue Moist Multifocal in a Japanese Population

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030247

Enrollment

134

Registered

2017-12-04

Start date

2017-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Error Presbyopia

Interventions

DT1MF, then AMMF Delefilcon A multifocal contact lenses, followed by etafilcon A multifocal contact lenses. Each product will be in both eyes for 14 +/- 3 days. AMMF, then DT1MF Etafilcon A multifoc

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Sign informed consent. -Habitually wear multifocal soft/ silicone hydrogel contact lenses -Require a near spectacle ADD of +0.50D to +2.50D (inclusive) -Correctable to 20/30 Snellen or 0.2 logarithm minimum angle of resolution (logMAR) or better in each eye at distance -Willing to wear contact lenses and attend all study visits -Other protocol-defined inclusion criteria may apply

Exclusion criteria

Exclusion criteria: -Currently wearing DAILIES TOTAL 1 Multifocal or 1-DAY ACUVUE Moist Multifocal contact lenses -Any eye condition that would make contact lens wear unadvisable -Any use of medication that would make contact lens wear unadvisable -Prior refractive surgery -Other protocol-defined exclusion criteria may apply

Design outcomes

Primary

Measure	Time frame
Investigator-graded lens centration of "Optimal" Lens centration will be assessed by slit-lamp microscopy and graded on a 5-point scale, where 0=Optimal/Centered and 4=Severe decentration (with corneal exposure)	—

Countries

Japan

Contacts

Public ContactMitsugu Watanabe

Alcon Japan Ltd. Medical Affairs, Clinical & Regulatory Affairs Division

mitsugu.watanabe@alcon.com03-6899-5054

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026